熱門資訊> 正文

Teanx Therapeutics计划进行二次发行

2025-04-16 14:57

Tenax Therapeutics(TENX) 0

Tenax Therapeutics (NASDAQ:TENX) filed a prospectus for resale by the selling stockholder of up to 378,346 shares of common stock and up to ~3.76M shares of common stock issuable upon the exercise of pre-funded warrants.
The company will not receive any proceeds from the sale.
Source: Form S-3 filing

More on Tenax Therapeutics

Tenax Therapeutics announces $25M private placement
Seeking Alpha’s Quant Rating on Tenax Therapeutics
Historical earnings data for Tenax Therapeutics
Financial information for Tenax Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。